Lighthervin Tablets 125 mg (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.
MFDS item code 202005675 · Approved 2020.08.05
This product's status changed to Expired on 2025.08.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of onychomycosis, cutaneous fungal infections (including tinea pedis and tinea corporis), and tinea capitis in children
This medication is effective for adults in treating athlete's foot, body ringworm, tinea corporis, and onychomycosis caused by dermatophytes. In children, it is used for the treatment of tinea capitis, thereby helping to improve symptoms of fungal infections on the skin and nails.
Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toes, or in younger patients, the treatment period may be shortened to 3 months or less. For toenail infections, 3 months of treatment is usually sufficient, but in some patients it may take 6 months or longer. The treatment period may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks 1) Body weight less than 20 kg (under 5 years): 62.5 mg per dose, once daily. As experience with use is limited, the decision to administer should be made after considering the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): 125 mg per dose, once daily. 3) Body weight over 40 kg (over 12 years): 250 mg per dose, once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. You must check your liver health status before taking this medication and undergo regular liver function tests. If any abnormalities in liver function occur, discontinue the medication immediately. Symptoms that may indicate liver dysfunction include persistent nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice (yellowing of the skin or eyes), dark urine, and pale stools; if any of these symptoms occur, consult a doctor right away. This drug may cause severe liver damage such as hepatic failure, and treatment should be stopped immediately if liver damage progresses. Additionally, patients with allergic reactions to this drug, blood disorders, severe renal failure, children under 2 years old, and breastfeeding women should not take this medication. Patients with lactose intolerance should also avoid this drug. Use this medication cautiously in patients with renal impairment, the elderly, and children weighing less than 20 kg. If severe rashes or allergic reactions occur, discontinue use immediately. Special caution is necessary for patients with psoriasis or systemic lupus erythematosus. This drug may cause various side effects, and liver function abnormalities, blood disorders, skin rashes, muscle pain, gastrointestinal disturbances, mental changes, and neurological symptoms have been reported. If any of these symptoms occur, consult a healthcare professional promptly. Be careful when driving or operating machinery, as symptoms such as dizziness may occur. This medication may interact with other drugs, so if you are currently taking any medications, you must inform your healthcare provider, especially when used in conjunction with drugs metabolized in the liver. Women who are pregnant or may become pregnant should only take this medication if the benefits outweigh the risks, and breastfeeding women should discontinue nursing while taking this medication. In case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur, so if these symptoms appear, visit a hospital immediately. Store this medication out of reach of children, away from direct sunlight, and at room temperature.
Persistent nausea, decreased appetite, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, decreased appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriasiform rash, psoriasis exacerbation, hair loss, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial swelling, lymphangiectasia, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, discomfort in the epigastric region, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory disturbances, sensory reduction, decreased attention, insomnia, elevated BUN, frequency of urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, superficial erythematous lupus, elevated total cholesterol in the blood, elevated triglycerides, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, impaired vision, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. This helps ensure the safety and efficacy of the medication.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.